Salvia BioElectronics
Eindhoven
About Salvia BioElectronics
Salvia BioElectronics develops innovative neuromodulation devices aimed at treating migraines. The company focuses on creating a paper-thin implant that delivers gentle electrical pulses to specific nerves, helping to alleviate migraine symptoms. Salvia BioElectronics is dedicated to advancing its technology through ongoing research and development efforts. With recent funding, the company works to bring its migraine therapy to market, offering a new approach to pain management for patients. The emphasis is on improving patient outcomes through effective neuromodulation therapy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $94.7M
- Funding stage: Early Stage Venture
- Last round: Series B (May 2025)
- Website: salviabioelectronics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/salvia-bioelectronics-51479 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.